CAS: 2070015-26-6

SRT3025 Hydrochloride is a synthetic small molecule, which is developed as an activator of the SIRT1 enzyme. SRT3025 is derived from chemical synthesis, designed specifically to modulate enzymatic activity associated with aging and metabolic regulation. The compound functions by enhancing the deacetylase activity of the SIRT1 enzyme, a member of the sirtuin family, which plays a crucial role in cellular processes related to longevity and metabolic regulation. Utilizing this activation mechanism, SRT3025 Hydrochloride is employed in scientific research to investigate its potential therapeutic effects on diseases related to metabolism and aging, such as type 2 diabetes, cardiovascular disease, and neurodegenerative disorders. It provides a valuable tool for understanding the biochemical pathways influenced by SIRT1 and can help illuminate the potential of sirtuin modulation as a therapeutic strategy. Researchers focus on its ability to mimic caloric restriction benefits and its implications in extending healthspan.

Sirtuin modulator 1 (SRT3025 Hydrochloride) is a modulator of SIRT1 with EC1.5 of < 1 μM.

5-(3-Methoxypropyl)-2-Phenyl-N-(2-(6-(Pyrrolidin-1-Ylmethyl)Thiazolo[5,4-B]Pyridin-2-Yl)Phenyl)Thiazole-4-Carboxamide Hydrochloride

Sirtuin modulator 1